Massive locally extensive prostate cancer.
Publication
, Journal Article
Rozanski, TA; Faerber, GJ
Published in: Urology
February 1994
A massive, locally extensive adenocarcinoma of the prostate (2,246 ccm) presenting as constipation and a palpable abdominal mass, was treated with androgen deprivation resulting in a 94 percent reduction in tumor size, and relief of symptoms. Serum prostate-specific antigen was reduced from 4,029 to 0.4 ng/mL, after hormonal therapy was combined with radiation treatments for local disease control.
Duke Scholars
Published In
Urology
DOI
ISSN
0090-4295
Publication Date
February 1994
Volume
43
Issue
2
Start / End Page
242 / 243
Location
United States
Related Subject Headings
- Urology & Nephrology
- Radiotherapy Dosage
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prostate
- Male
- Leuprolide
- Humans
- Flutamide
- Constipation
Citation
APA
Chicago
ICMJE
MLA
NLM
Rozanski, T. A., & Faerber, G. J. (1994). Massive locally extensive prostate cancer. Urology, 43(2), 242–243. https://doi.org/10.1016/0090-4295(94)90054-x
Rozanski, T. A., and G. J. Faerber. “Massive locally extensive prostate cancer.” Urology 43, no. 2 (February 1994): 242–43. https://doi.org/10.1016/0090-4295(94)90054-x.
Rozanski TA, Faerber GJ. Massive locally extensive prostate cancer. Urology. 1994 Feb;43(2):242–3.
Rozanski, T. A., and G. J. Faerber. “Massive locally extensive prostate cancer.” Urology, vol. 43, no. 2, Feb. 1994, pp. 242–43. Pubmed, doi:10.1016/0090-4295(94)90054-x.
Rozanski TA, Faerber GJ. Massive locally extensive prostate cancer. Urology. 1994 Feb;43(2):242–243.
Published In
Urology
DOI
ISSN
0090-4295
Publication Date
February 1994
Volume
43
Issue
2
Start / End Page
242 / 243
Location
United States
Related Subject Headings
- Urology & Nephrology
- Radiotherapy Dosage
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prostate
- Male
- Leuprolide
- Humans
- Flutamide
- Constipation